The Enterprise Value as of December 2025 (TTM) for FibroBiologics, Inc. Common Stock (FBLG) is 12.83M

According to FibroBiologics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 12.83M. This represents a change of -76.35% compared to the average of 54.26M of the last 4 quarters.

FibroBiologics, Inc. Common Stock (FBLG) Historical Enterprise Value (quarterly & annually)

How has FBLG Enterprise Value performed in the past?

The mean historical Enterprise Value of FibroBiologics, Inc. Common Stock over the last ten years is 579.57M. The current 12.83M Enterprise Value has changed 121.37% with respect to the historical average. Over the past ten years (40 quarters), FBLG's Enterprise Value was at its highest in in the March 2023 quarter at 952.13M. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.

FibroBiologics, Inc. Common Stock (FBLG) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of FibroBiologics, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

FibroBiologics, Inc. Common Stock (FBLG) Average Enterprise Value

How has FBLG Enterprise Value performed in the past?

The current Enterprise Value of FibroBiologics, Inc. Common Stock (FBLG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

FibroBiologics, Inc. Common Stock (FBLG) Enterprise Value vs. Peers

How is FBLG’s Enterprise Value compared to its peers?

FibroBiologics, Inc. Common Stock’s Enterprise Value is greater than Daré Bioscience, Inc. (-3098933.00), greater than Athira Pharma, Inc. (-4600560.00), greater than Aditxt, Inc. (5.43M), less than Ainos, Inc. (21.90M), greater than Citius Pharmaceuticals, Inc. (8.76M), greater than Moleculin Biotech, Inc. (3.01M), less than Leap Therapeutics, Inc. (53.86M), greater than Apollomics, Inc. (7.47M), greater than SeaStar Medical Holding Corporation (-3752301.00), greater than Hoth Therapeutics, Inc. (6.79M),

Build a custom stock screener for FibroBiologics, Inc. Common Stock (FBLG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like FibroBiologics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

FibroBiologics, Inc. Common Stock (FBLG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like FibroBiologics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.